ENZON PHARMACEUTICALS, INC.

ENZN CIK: 727510 Manufacturing Chemicals & Allied Products

CRANFORD, NJ

Financials

Price History

Market Data

Market Cap	482.39M
P/E Ratio	-
P/B Ratio	-
EPS	-0.07
Dividend Yield	-
D/E Ratio	-
Current Ratio	58.57
Currency	USD

Key Financial Metrics

Revenue

-3.41M

Net Income

-0.07

EPS (Diluted)

-4.92M

Free Cash Flow

Profitability

Gross Margin -

Operating Margin -

Net Profit Margin -

EBITDA -5.31M

Returns & Efficiency

Return on Assets (ROA) -8.0%

Return on Equity (ROE) -

Dividend Yield -

EPS -0.07

Financial Health

Total Assets 42.81M

Total Debt -

Debt to Equity -

Current Ratio 58.57

Insider Trading Last 12 months

Buys

Sells

Insiders

Quick Access Filings

10-K

Annual Report

10-Q

Quarterly Report

8-K

Company Data Library

Earnings Transcripts

Press Releases

Filing Sections

Company Info

Industry	Chemicals & Allied Products
HQ	CRANFORD, NJ
Fiscal Year	2025

Peers

AMGEN INC

AMGN

177.13B

P/E: --

GILEAD SCIENCES INC

GILD

166.13B

P/E: --

GILEAD SCIENCES, INC.

GILD

166.13B

P/E: --

BIOGEN IDEC INC.

BIIB

27.90B

P/E: --

BIOGEN INC.

BIIB

27.90B

P/E: --

REVOLUTION MEDICINES, INC.

RVMD

19.11B

P/E: --

MODERNA, INC.

MRNA

18.38B

P/E: --

Moderna, Inc.

MRNA

18.38B

P/E: --

Quick Links

Full Financials Advanced Charts Filings

Financial Statistics

Valuation

Market Cap$482.39M

P/E Ratio (TTM)-

Price to Book-

EV/Revenue-

EV/EBITDA-

Profitability

Gross Margin-

Operating Margin-

Net Margin-

ROE-

ROA-8.0%

Leverage & Liquidity

Debt to Equity-

Current Ratio58.57

Total Debt-

Total Assets$42.81M

Stockholders' Equity$-2.52M

Income Statement (FY 2025)

Revenue-

Gross Profit-

Operating Income$-5.31M

Net Income$-3.41M

EPS (Diluted)$-0.07

Cash Flow (FY 2025)

Free Cash Flow$-4.92M

Cash & Equivalents$42.57M

Revenue Growth-

SEC Filings by Category

Financial Reports

Insider Trading Activity

Neutral 0 Buys $0 0 Sales $0 0 Exercises $0 Net: $0

Insider	Title	Date	Type	Shares	Price	Value

Company Information

Business Address	20 COMMERCE DRIVE, SUITE 135 CRANFORD, NJ 07016
Phone	732-980-4500
Incorporated	DE, US
EIN	222372868
Fiscal Year End	1231
Shares Outstanding	74.21M
Stockholders' Equity	$-2.52M
Cash & Equivalents	$42.57M

Recent Filings View All

10-Q Quarterly Report

Quarterly financial report with unaudited statements

Filed: 2026-05-04

Local

10-K/A Amended Annual Report

Amendment to previously filed annual report

Filed: 2026-04-29

Local

8-K Current Report

Report of material events (acquisitions, earnings, executive changes)

Filed: 2026-04-21

Local

8-K Current Report

Report of material events (acquisitions, earnings, executive changes)

Filed: 2026-04-16

Local

8-K Current Report

Report of material events (acquisitions, earnings, executive changes)

Filed: 2026-04-15

Local

3 Initial Ownership Report